Benyi Li, MD/PhD, Professor of Urology and Cancer Biology
Benyi Li, MD/PhD, Professor of Urology and Cancer Biology
KUMC Urology Research Lab
Dirección de correo verificada de kumc.edu - Página principal
Título
Citado por
Citado por
Año
Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression
B Li, QP Dou
Proceedings of the National Academy of Sciences 97 (8), 3850-3855, 2000
5642000
GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome
M Pi, L Chen, MZ Huang, W Zhu, B Ringhofer, J Luo, L Christenson, B Li, ...
PloS one 3 (12), e3858, 2008
2122008
Small-interfering RNA–induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
X Liao, S Tang, JB Thrasher, TL Griebling, B Li
Molecular cancer therapeutics 4 (4), 505-515, 2005
2052005
Proteasome inhibitors as potential novel anticancer agents
QP Dou, B Li
Drug Resistance Updates 2 (4), 215-223, 1999
1901999
Association of testosterone and sex hormone–binding globulin with metabolic syndrome and insulin resistance in men
C Li, ES Ford, B Li, WH Giles, S Liu
Diabetes care 33 (7), 1618-1624, 2010
1872010
Glycogen synthase kinase-3β suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer
X Liao, L Zhang, JB Thrasher, J Du, B Li
Molecular cancer therapeutics 2 (11), 1215-1222, 2003
1262003
Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer
X Liao, JB Thrasher, J Pelling, J Holzbeierlein, QXA Sang, B Li
Endocrinology 144 (5), 1656-1663, 2003
1152003
Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824
L Chen, S Meng, H Wang, P Bali, W Bai, B Li, P Atadja, KN Bhalla, J Wu
Molecular cancer therapeutics 4 (9), 1311-1319, 2005
1132005
Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers
A Sun, O Tawfik, B Gayed, JB Thrasher, S Hoestje, C Li, B Li
The Prostate 67 (2), 203-213, 2007
1122007
Glycogen synthase kinase-3β activity is required for androgen-stimulated gene expression in prostate cancer
X Liao, JB Thrasher, J Holzbeierlein, S Stanley, B Li
Endocrinology 145 (6), 2941-2949, 2004
1072004
CEP1612, a dipeptidyl proteasome inhibitor, induces p21WAF1 and p27KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice
J Sun, S Nam, CS Lee, B Li, D Coppola, AD Hamilton, QP Dou, SM Sebti
Cancer research 61 (4), 1280-1284, 2001
962001
Lupeol inhibits proliferation of human prostate cancer cells by targeting β-catenin signaling
M Saleem, I Murtaza, RS Tarapore, Y Suh, VM Adhami, JJ Johnson, ...
Carcinogenesis 30 (5), 808-817, 2009
952009
Phosphoinositide 3-OH kinase p85α and p110β are essential for androgen receptor transactivation and tumor progression in prostate cancers
Q Zhu, H Youn, J Tang, O Tawfik, K Dennis, PF Terranova, J Du, P Raynal, ...
Oncogene 27 (33), 4569-4579, 2008
922008
Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy
P Chen, J Yu, B Chalmers, J Drisko, J Yang, B Li, Q Chen
Anti-cancer drugs 23 (4), 437-444, 2012
872012
Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo
Q Zhu, J Yang, S Han, J Liu, J Holzbeierlein, JB Thrasher, B Li
The Prostate 71 (8), 835-845, 2011
832011
Serum/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival
I Shanmugam, G Cheng, PF Terranova, JB Thrasher, CP Thomas, B Li
Cell death & differentiation 14 (12), 2085-2094, 2007
722007
Lithium suppresses cell proliferation by interrupting E2F–DNA interaction and subsequently reducing S–phase gene expression in prostate cancer
A Sun, I Shanmugam, J Song, PF Terranova, JB Thrasher, B Li
The Prostate 67 (9), 976-988, 2007
722007
GSK-3β promotes cell survival by modulating Bif-1-dependent autophagy and cell death
J Yang, Y Takahashi, E Cheng, J Liu, PF Terranova, B Zhao, JB Thrasher, ...
Journal of cell science 123 (6), 861-870, 2010
692010
Development of a peptide–drug conjugate for prostate cancer therapy
W Tai, RS Shukla, B Qin, B Li, K Cheng
Molecular pharmaceutics 8 (3), 901-912, 2011
662011
A novel conditional Akt ‘survival switch’reversibly protects cells from apoptosis
B Li, SA Desai, RA MacCorkle-Chosnek, L Fan, DM Spencer
Gene therapy 9 (4), 233-244, 2002
662002
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20